504 related articles for article (PubMed ID: 25557356)
1. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
Yamada C; Teener JW; Davenport RD; Cooling L
J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
[TBL] [Abstract][Full Text] [Related]
2. Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis.
Yamada C; Pham HP; Wu Y; Cooling L; Kim HC; Morgan S; Schwartz J; Winters JL; Wong EC
J Clin Apher; 2017 Feb; 32(1):5-11. PubMed ID: 26946363
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
4. [Therapy for anti-MuSK antibody positive myasthenia gravis].
Pál Z; Boczán J; Bereznai B; Lovas G; Molnár MJ
Orv Hetil; 2011 Sep; 152(39):1586-9. PubMed ID: 21920845
[TBL] [Abstract][Full Text] [Related]
5. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
Guptill JT; Sanders DB; Evoli A
Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of MuSK antibody positive seronegative MG.
Sanders DB; El-Salem K; Massey JM; McConville J; Vincent A
Neurology; 2003 Jun; 60(12):1978-80. PubMed ID: 12821744
[TBL] [Abstract][Full Text] [Related]
7. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
[TBL] [Abstract][Full Text] [Related]
9. MuSK-positive myasthenia gravis is rare in the Polish population.
Kostera-Pruszczyk A; Kamińska A; Dutkiewicz M; Emeryk-Szajewska B; Strugalska-Cynowska MH; Vincent A; Kwieciński H
Eur J Neurol; 2008 Jul; 15(7):720-4. PubMed ID: 18494794
[TBL] [Abstract][Full Text] [Related]
10. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
[TBL] [Abstract][Full Text] [Related]
12. Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
Deguchi K; Matsuzono K; Nakano Y; Kono S; Sato K; Deguchi S; Tanabe K; Hishikawa N; Ota Y; Yamashita T; Ohta K; Motomura M; Abe K
Intern Med; 2018 May; 57(10):1455-1458. PubMed ID: 29321424
[TBL] [Abstract][Full Text] [Related]
13. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis patients with anti-MuSK antibodies.
Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
[TBL] [Abstract][Full Text] [Related]
15. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
[TBL] [Abstract][Full Text] [Related]
16. Complete stable remission and autoantibody specificity in myasthenia gravis.
Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.
Stein B; Bird SJ
J Clin Neuromuscul Dis; 2011 Mar; 12(3):163-4. PubMed ID: 21321497
[No Abstract] [Full Text] [Related]
18. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
[TBL] [Abstract][Full Text] [Related]
19. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
[TBL] [Abstract][Full Text] [Related]
20. Are MuSK antibodies the primary cause of myasthenic symptoms?
Selcen D; Fukuda T; Shen XM; Engel AG
Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
